Last 12 months
Inside the activity.
0 purchase rows · 55 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 7 |
| Jan 2026 | 0 | 15 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2021 Filed Mar 11, 2021 16:55 UTC |
Warren MiriamChief Diversity Officer
|
SaleCommon Stock | 8,200 | $40.00 | $328,000.00 |
DisclosureSEC source: 0001850752-21-000004 · wf-form4_161549969924957.xml · nonDerivative · entry 2 Warren Miriam · CIK 0001850752 · Chief Diversity Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,107 F1 · shares: Shares were sold pursuant to a duly adopted 10b5-1 trading plan, adopted by the reporting person on November 30, 2020. Read SEC document |
| March 08, 2021 Filed Mar 11, 2021 16:55 UTC |
Warren MiriamChief Diversity Officer
|
Exercise / conversionCommon Stock | 8,200 | $27.60 | $226,320.00 |
DisclosureSEC source: 0001850752-21-000004 · wf-form4_161549969924957.xml · nonDerivative · entry 1 Warren Miriam · CIK 0001850752 · Chief Diversity Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:00 UTC |
Patel VivekChief Product Officer
|
GrantCommon Stock | 44,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018285 · doc4.xml · nonDerivative · entry 1 Patel Vivek · CIK 0001770687 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,038 F1 · shares: On September 14, 2020, the Reporting Person was granted performance-based restricted stock units covering 25,489 shares of the Issuer's common stock at the target performance level, zero to 200% of which would become eligible to vest based on the achievement of performance goals. On March 3, 2021, the performance criteria were met, resulting in 44,076 shares becoming eligible to vest according to the following schedule, subject to the Reporting Person's continued service with the Issuer: 37.5% of the shares will vest on May 20, 2021; and 6.25% of the shares will vest each August 20, November 20, February 20 and May 20 thereafter until fully vested. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:00 UTC |
Schwarzbach David AChief Financial Officer
|
GrantCommon Stock | 29,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018284 · doc4.xml · nonDerivative · entry 1 Schwarzbach David A · CIK 0001349334 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,399 F1 · shares: On September 14, 2020, the Reporting Person was granted performance-based restricted stock units covering 16,993 shares of the Issuer's common stock at the target performance level, zero to 200% of which would become eligible to vest based on the achievement of performance goals. On March 3, 2021, the performance criteria were met, resulting in 29,385 shares becoming eligible to vest according to the following schedule, subject to the Reporting Person's continued service with the Issuer: 37.5% of the shares will vest on May 20, 2021; and 6.25% of the shares will vest each August 20, November 20, February 20 and May 20 thereafter until fully vested. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
GrantCommon Stock | 119,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018286 · doc4.xml · nonDerivative · entry 1 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,297 F1 · shares: On September 14, 2020, the Reporting Person was granted performance-based restricted stock units covering 69,033 shares of the Issuer's common stock at the target performance level, zero to 200% of which would become eligible to vest based on the achievement of performance goals. On March 3, 2021, the performance criteria were met, resulting in 119,372 shares becoming eligible to vest according to the following schedule, subject to the Reporting Person's continued service with the Issuer: 37.5% of the shares will vest on May 20, 2021; and 6.25% of the shares will vest each August 20, November 20, February 20 and May 20 thereafter until fully vested. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:00 UTC |
Wilson LaurenceChief Administrative Officer
|
GrantCommon Stock | 36,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018281 · doc4.xml · nonDerivative · entry 1 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,494 F1 · shares: On September 14, 2020, the Reporting Person was granted performance-based restricted stock units covering 21,241 shares of the Issuer's common stock at the target performance level, zero to 200% of which would become eligible to vest based on the achievement of performance goals. On March 3, 2021, the performance criteria were met, resulting in 36,730 shares becoming eligible to vest according to the following schedule, subject to the Reporting Person's continued service with the Issuer: 37.5% of the shares will vest on May 20, 2021; and 6.25% of the shares will vest each August 20, November 20, February 20 and May 20 thereafter until fully vested. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 22:00 UTC |
Nachman Joseph RChief Operating Officer
|
GrantCommon Stock | 55,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-018282 · doc4.xml · nonDerivative · entry 1 Nachman Joseph R · CIK 0001540652 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,930 F1 · shares: On September 14, 2020, the Reporting Person was granted performance-based restricted stock units covering 31,861 shares of the Issuer's common stock at the target performance level, zero to 200% of which would become eligible to vest based on the achievement of performance goals. On March 3, 2021, the performance criteria were met, resulting in 55,094 shares becoming eligible to vest according to the following schedule, subject to the Reporting Person's continued service with the Issuer: 37.5% of the shares will vest on May 20, 2021; and 6.25% of the shares will vest each August 20, November 20, February 20 and May 20 thereafter until fully vested. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:01 UTC |
Barone ChristineDirector
|
GrantCommon Stock | 1,010 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017314 · doc4.xml · nonDerivative · entry 1 Barone Christine · CIK 0001804370 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,233 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over one year from the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:00 UTC |
IRVINE DIANE MDirector
|
GrantCommon Stock | 2,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017312 · doc4.xml · nonDerivative · entry 1 IRVINE DIANE M · CIK 0001287611 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,687 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over one year from the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 19:00 UTC |
ANDERSON FRED DDirector
|
GrantCommon Stock | 1,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017315 · doc4.xml · nonDerivative · entry 1 ANDERSON FRED D · CIK 0001211665 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,878 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over one year from the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:00 UTC |
Hu GeorgeDirector
|
GrantCommon Stock | 1,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017311 · doc4.xml · nonDerivative · entry 1 Hu George · CIK 0001386396 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,104 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over one year from the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 00:00 UTC |
Gibbs Robert LaneDirector
|
GrantCommon Stock | 1,272 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017306 · doc4.xml · nonDerivative · entry 1 Gibbs Robert Lane · CIK 0001551440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,997 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over one year from the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 4, 2021 21:30 UTC |
SHARPLES BRIANDirector
|
GrantCommon Stock | 1,196 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017808 · doc4.xml · nonDerivative · entry 1 SHARPLES BRIAN · CIK 0001034604 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,725 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over one year from the date of grant. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 00:00 UTC |
Wilson LaurenceChief Administrative Officer
|
SaleCommon Stock | 292 | $36.15 | $10,555.80 |
DisclosureSEC source: 0001209191-21-013985 · doc4.xml · nonDerivative · entry 3 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,764 F2 · shares: Shares were sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on December 1, 2020. F4 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $36.04 to $36.23, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 00:00 UTC |
Wilson LaurenceChief Administrative Officer
|
SaleCommon Stock | 3,441 | $35.46 | $122,017.86 |
DisclosureSEC source: 0001209191-21-013985 · doc4.xml · nonDerivative · entry 2 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,056 F2 · shares: Shares were sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on December 1, 2020. F3 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $34.98 to $35.84, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 00:00 UTC |
Wilson LaurenceChief Administrative Officer
|
Tax withholdingCommon Stock | 2,715 | $37.51 | $101,839.65 |
DisclosureSEC source: 0001209191-21-013985 · doc4.xml · nonDerivative · entry 1 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,497 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 00:00 UTC |
Patel VivekChief Product Officer
|
Tax withholdingCommon Stock | 3,146 | $37.51 | $118,006.46 |
DisclosureSEC source: 0001209191-21-013984 · doc4.xml · nonDerivative · entry 1 Patel Vivek · CIK 0001770687 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,962 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 00:00 UTC |
Schwarzbach David AChief Financial Officer
|
Tax withholdingCommon Stock | 5,230 | $37.51 | $196,177.30 |
DisclosureSEC source: 0001209191-21-013983 · doc4.xml · nonDerivative · entry 1 Schwarzbach David A · CIK 0001349334 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,014 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 00:00 UTC |
Nachman Joseph RChief Operating Officer
|
Tax withholdingCommon Stock | 4,019 | $37.51 | $150,752.69 |
DisclosureSEC source: 0001209191-21-013982 · doc4.xml · nonDerivative · entry 1 Nachman Joseph R · CIK 0001540652 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,836 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. Read SEC document |
| February 22, 2021 Filed Feb 25, 2021 00:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 6,632 | $37.51 | $248,766.32 |
DisclosureSEC source: 0001209191-21-013981 · doc4.xml · nonDerivative · entry 1 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,925 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:00 UTC |
Wilson LaurenceChief Administrative Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $21.18 | $0.00 |
DisclosureSEC source: 0001209191-21-011906 · doc4.xml · derivative · entry 4 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,500 Underlying: Common Stock · 25,000 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully vested. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:00 UTC |
Wilson LaurenceChief Administrative Officer
|
SaleCommon Stock | 5,138 | $37.10 | $190,619.80 |
DisclosureSEC source: 0001209191-21-011906 · doc4.xml · nonDerivative · entry 3 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,212 F1 · shares: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan, adopted by the reporting person on December 1, 2020. F3 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $37.06 to $37.21, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:00 UTC |
Wilson LaurenceChief Administrative Officer
|
SaleCommon Stock | 34,022 | $36.77 | $1,250,988.94 |
DisclosureSEC source: 0001209191-21-011906 · doc4.xml · nonDerivative · entry 2 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,350 F1 · shares: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan, adopted by the reporting person on December 1, 2020. F2 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $36.05 to $37.05, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 22:00 UTC |
Wilson LaurenceChief Administrative Officer
|
GrantCommon Stock | 25,000 | $21.18 | $529,500.00 |
DisclosureSEC source: 0001209191-21-011906 · doc4.xml · nonDerivative · entry 1 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,372 F1 · shares: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan, adopted by the reporting person on December 1, 2020. Read SEC document |
| February 05, 2021 Filed Feb 10, 2021 00:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
GrantCommon Stock | 119,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008984 · doc4.xml · nonDerivative · entry 1 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,557 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over four years from the date of grant. Read SEC document |
| February 05, 2021 Filed Feb 10, 2021 00:00 UTC |
Schwarzbach David AChief Financial Officer
|
GrantCommon Stock | 51,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008983 · doc4.xml · nonDerivative · entry 1 Schwarzbach David A · CIK 0001349334 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,244 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over four years from the date of grant. Read SEC document |
| February 05, 2021 Filed Feb 10, 2021 00:00 UTC |
Nachman Joseph RChief Operating Officer
|
GrantCommon Stock | 59,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008982 · doc4.xml · nonDerivative · entry 1 Nachman Joseph R · CIK 0001540652 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,855 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over four years from the date of grant. Read SEC document |
| February 05, 2021 Filed Feb 10, 2021 00:00 UTC |
Wilson LaurenceChief Administrative Officer
|
GrantCommon Stock | 34,119 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008981 · doc4.xml · nonDerivative · entry 1 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,372 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over four years from the date of grant. Read SEC document |
| February 05, 2021 Filed Feb 10, 2021 00:00 UTC |
Patel VivekChief Product Officer
|
GrantCommon Stock | 37,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-008980 · doc4.xml · nonDerivative · entry 1 Patel Vivek · CIK 0001770687 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,108 F1 · shares: Represents the grant of restricted stock units that vest in equal quarterly installments over four years from the date of grant. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 23:26 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 346,830 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001209191-21-002319 · doc4.xml · derivative · entry 6 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 346,830 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Fully vested. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 23:26 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
SaleCommon Stock | 10,130 | $32.52 | $329,427.60 |
DisclosureSEC source: 0001209191-21-002319 · doc4.xml · nonDerivative · entry 5 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,140 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. F5 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $32.32 to $32.68, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 23:26 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
SaleCommon Stock | 12,983 | $31.56 | $409,743.48 |
DisclosureSEC source: 0001209191-21-002319 · doc4.xml · nonDerivative · entry 4 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,270 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. F4 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $31.29 to $32.04, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 23:26 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
SaleCommon Stock | 51,991 | $30.53 | $1,587,285.23 |
DisclosureSEC source: 0001209191-21-002319 · doc4.xml · nonDerivative · entry 3 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,253 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. F3 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $30.25 to $30.95, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 23:26 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
SaleCommon Stock | 271,726 | $29.71 | $8,072,979.46 |
DisclosureSEC source: 0001209191-21-002319 · doc4.xml · nonDerivative · entry 2 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,244 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. F2 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $29.24 to $30.24, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 23:26 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
GrantCommon Stock | 346,830 | $7.16 | $2,483,302.80 |
DisclosureSEC source: 0001209191-21-002319 · doc4.xml · nonDerivative · entry 1 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,970 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 23:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001209191-20-064174 · doc4.xml · derivative · entry 3 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 346,830 Underlying: Common Stock · 400,000 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 23:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
SaleCommon Stock | 400,000 | $28.54 | $11,416,000.00 |
DisclosureSEC source: 0001209191-20-064174 · doc4.xml · nonDerivative · entry 2 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,140 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. F2 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $28.17 to $28.99, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 23:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
GrantCommon Stock | 400,000 | $7.16 | $2,864,000.00 |
DisclosureSEC source: 0001209191-20-064174 · doc4.xml · nonDerivative · entry 1 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,140 Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:23 UTC |
Wells Royce A.Director
|
GrantStock Option (Right to Buy) · Derivative | 11,550 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001559292-20-000006 · wf-form4_160815737689829.xml · derivative · entry 2 Wells Royce A. · CIK 0001559292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,550 Underlying: Common Stock · 11,550 shares Expires 2030-12-14 F2 · derivative.exercise_date: The shares underlying the stock option vest as follows: (a) 25% of the shares vest on October 30, 2021, then (b) the remaining shares vest in equal monthly installments over the following 36 months. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:23 UTC |
Wells Royce A.Director
|
GrantCommon Stock | 5,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001559292-20-000006 · wf-form4_160815737689829.xml · nonDerivative · entry 1 Wells Royce A. · CIK 0001559292 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,674 F1 · shares: Represents the grant of restricted stock units that vest as follows: (a) 25% on November 20, 2021, then (b) the remaining shares vest in equal quarterly installments over the following three years. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 23:58 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001209191-20-063063 · doc4.xml · derivative · entry 3 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 746,830 Underlying: Common Stock · 400,000 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 23:58 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
SaleCommon Stock | 400,000 | $30.55 | $12,220,000.00 |
DisclosureSEC source: 0001209191-20-063063 · doc4.xml · nonDerivative · entry 2 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,140 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. F2 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $29.87 to $30.87, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| December 10, 2020 Filed Dec 11, 2020 23:58 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
GrantCommon Stock | 400,000 | $7.16 | $2,864,000.00 |
DisclosureSEC source: 0001209191-20-063063 · doc4.xml · nonDerivative · entry 1 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,140 Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $7.16 | $0.00 |
DisclosureSEC source: 0001209191-20-061520 · doc4.xml · derivative · entry 3 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,830 Underlying: Common Stock · 400,000 shares Expires 2021-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
SaleCommon Stock | 400,000 | $32.31 | $12,924,000.00 |
DisclosureSEC source: 0001209191-20-061520 · doc4.xml · nonDerivative · entry 2 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,140 F1 · kind: Shares were acquired and sold pursuant to a duly adopted 10b5-1 trading plan adopted by the reporting person on February 18, 2020 and amended on May 15, 2020. F2 · price: The sales price reported is the weighted average sale price for the number of shares sold. These shares were sold in multiple transactions at prices ranging from $31.81 to $32.54, inclusive. Full information regarding the number of shares sold at each separate price will be supplied upon request by Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 22:00 UTC |
Stoppelman JeremyDirector · Chief Executive Officer
|
GrantCommon Stock | 400,000 | $7.16 | $2,864,000.00 |
DisclosureSEC source: 0001209191-20-061520 · doc4.xml · nonDerivative · entry 1 Stoppelman Jeremy · CIK 0001541476 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,140 Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:00 UTC |
Nachman Joseph RChief Operating Officer
|
Tax withholdingCommon Stock | 3,705 | $32.22 | $119,375.10 |
DisclosureSEC source: 0001209191-20-060250 · doc4.xml · nonDerivative · entry 1 Nachman Joseph R · CIK 0001540652 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,146 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:00 UTC |
Patel VivekChief Product Officer
|
Tax withholdingCommon Stock | 4,660 | $32.22 | $150,145.20 |
DisclosureSEC source: 0001209191-20-060247 · doc4.xml · nonDerivative · entry 1 Patel Vivek · CIK 0001770687 · Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,577 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:00 UTC |
Wilson LaurenceChief Administrative Officer
|
Tax withholdingCommon Stock | 1,978 | $32.22 | $63,731.16 |
DisclosureSEC source: 0001209191-20-060248 · doc4.xml · nonDerivative · entry 1 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,253 F1 · shares: Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:30 UTC |
Wilson LaurenceChief Administrative Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $21.18 | $0.00 |
DisclosureSEC source: 0001209191-20-059658 · doc4.xml · derivative · entry 3 Wilson Laurence · CIK 0001539846 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,500 Underlying: Common Stock · 12,500 shares Expires 2023-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.